Partial Disposal of Shares in SkinBioTherapeutics

AI SummaryClose X

OptiBiotix Health plc has partially disposed of its shareholding in SkinBioTherapeutics plc, selling 7,500,000 ordinary shares for £675,000 in cash. These proceeds will be used for general working capital, extending the company's runway into the first half of 2027. Following this sale, OptiBiotix retains 5,700,000 ordinary shares in SkinBioTherapeutics, representing 2.2% of its total issued share capital.

Disclaimer*

UK 100

Latest directors dealings